Skip to content
Prev 2593 / 5636 Next

[R-meta] metagen / low heterogeneity

On 11/01/2021 16:45, Sean wrote:
The crucial thing is the scientific context. I do not work in the same 
area as you so my examples are from my field, not yours, but I hope are 
helpful.

If the primary studies were all very similar then you would not expect 
heterogeneity and you might be prompted to look for explanations for 
even mild amounts. For instance if all the primary studies had studied 
the same dose of drug in people with very tightly defined illness in 
countries with very similar health care symptoms then any heterogeneity 
might lead you, post hoc, to find out why.

If on the contrary the studies had examined a complex health care 
systems intervention in countries across the globe in patients who might 
vary considerably then you would be very surprised not to see 
heterogeneity. In that case you would be less inclined to look for 
explanations.

If you had a theory that outcomes were related to some other variable 
then you might use that as a moderator irrespective of the amount of 
heterogeneity. For instance in a study of a skills-based therapy you 
might have a theory that outcomes are different now from what they used 
to be so you would find it worth while looking at that whatever. For 
instance is centres in each study have been doing a particular operation 
for different amounts of time do the ones who have been doing it for 
longest have have better or worse outcomes.

Michael